Regeneron Pharmaceuticals (REGN) Operating Income Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.69% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 75.16% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -347.04% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 80.62% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 1.27% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.65% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,386.07% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.65% |
| Dec 31, 2025 | -11.14% |
| Sep 30, 2025 | -12.95% |
| Jun 30, 2025 | 0.93% |
| Mar 31, 2025 | -21.25% |
| Dec 31, 2024 | 1.78% |
| Sep 30, 2024 | 6.17% |
| Jun 30, 2024 | 5.22% |
| Mar 31, 2024 | -20.63% |
| Dec 31, 2023 | -15.16% |
| Sep 30, 2023 | -9.21% |
| Jun 30, 2023 | -8.42% |
| Mar 31, 2023 | -24.78% |
| Dec 31, 2022 | -56.56% |
| Sep 30, 2022 | -33.75% |
| Jun 30, 2022 | -66.84% |
| Mar 31, 2022 | 13.10% |
| Dec 31, 2021 | 126.20% |
| Sep 30, 2021 | 75.41% |
| Jun 30, 2021 | 409.93% |
| Mar 31, 2021 | 58.93% |
| Dec 31, 2020 | 72.71% |
| Sep 30, 2020 | 42.60% |
| Jun 30, 2020 | 107.98% |
| Mar 31, 2020 | 45.85% |
| Dec 31, 2019 | -5.90% |
| Sep 30, 2019 | 17.80% |
| Jun 30, 2019 | -49.28% |
| Mar 31, 2019 | -15.37% |
| Dec 31, 2018 | 33.27% |
| Sep 30, 2018 | 11.96% |
| Jun 30, 2018 | 13.06% |
| Mar 31, 2018 | 31.74% |
| Dec 31, 2017 | 55.30% |
| Sep 30, 2017 | 54.33% |
| Jun 30, 2017 | 88.70% |
| Mar 31, 2017 | 30.74% |
| Dec 31, 2016 | 50.15% |
| Sep 30, 2016 | -7.55% |
| Jun 30, 2016 | -15.44% |
| Mar 31, 2016 | 16.14% |
| Dec 31, 2015 | -6.58% |
| Sep 30, 2015 | 108.22% |
| Jun 30, 2015 | 51.19% |
| Mar 31, 2015 | 48.02% |
| Dec 31, 2014 | 26.79% |
| Sep 30, 2014 | -20.41% |
| Jun 30, 2014 | 44.27% |
| Mar 31, 2014 | 25.16% |
| Dec 31, 2013 | 33.93% |
| Sep 30, 2013 | 17.02% |
| Jun 30, 2013 | 80.73% |
| Mar 31, 2013 | 589.38% |
| Dec 31, 2012 | 420.84% |
| Sep 30, 2012 | 446.18% |
| Jun 30, 2012 | 245.03% |
| Mar 31, 2012 | 154.17% |
| Dec 31, 2011 | -255.34% |
| Sep 30, 2011 | -82.14% |
| Jun 30, 2011 | -154.25% |
| Mar 31, 2011 | -41.92% |
| Dec 31, 2010 | 67.58% |
| Sep 30, 2010 | -2,385.98% |
| Jun 30, 2010 | -45.85% |